These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 6094649)
1. The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis. Caniggia A; Nuti R; Loré F; Vattimo A J Endocrinol Invest; 1984 Aug; 7(4):373-8. PubMed ID: 6094649 [TBL] [Abstract][Full Text] [Related]
2. Effect of long term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis. Riggs BL; Nelson KI J Clin Endocrinol Metab; 1985 Sep; 61(3):457-61. PubMed ID: 3926808 [TBL] [Abstract][Full Text] [Related]
3. Prevention of bone mineral loss in postmenopausal women by norethisterone. Abdalla HI; Hart DM; Lindsay R; Leggate I; Hooke A Obstet Gynecol; 1985 Dec; 66(6):789-92. PubMed ID: 4069480 [TBL] [Abstract][Full Text] [Related]
4. Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis. Caniggia A; Delling G; Nuti R; Lorè F; Vattimo A Acta Vitaminol Enzymol; 1984; 6(2):117-28. PubMed ID: 6388277 [TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Dose response relationship of calcium absorption and indices of bone turnover. Need AG; Horowitz M; Philcox JC; Nordin BE Miner Electrolyte Metab; 1985; 11(1):35-40. PubMed ID: 3838358 [TBL] [Abstract][Full Text] [Related]
6. Effects of norethisterone on bone related biochemical variables and forearm bone mineral in post-menopausal osteoporosis. Horowitz M; Wishart JM; Need AG; Morris HA; Nordin BE Clin Endocrinol (Oxf); 1993 Dec; 39(6):649-55. PubMed ID: 8287582 [TBL] [Abstract][Full Text] [Related]
7. Effects of a short course of estrogen on mineral metabolism in postmenopausal women. Stock JL; Coderre JA; Mallette LE J Clin Endocrinol Metab; 1985 Oct; 61(4):595-600. PubMed ID: 2993339 [TBL] [Abstract][Full Text] [Related]
8. Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women. Need AG; Morris HA; Hartley TF; Horowitz M; Nordin BE Calcif Tissue Int; 1987 Jul; 41(1):7-10. PubMed ID: 3113703 [TBL] [Abstract][Full Text] [Related]
9. Biochemical effects of calcium supplementation in postmenopausal osteoporosis. Horowitz M; Need AG; Morris HA; Wishart J; Nordin BE Eur J Clin Nutr; 1988 Sep; 42(9):775-8. PubMed ID: 3181110 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of patients with postmenopausal osteoporosis and steroid-induced osteoporosis with the preparation Rocaltrol (1,25/OH/2 vitamin D3)]. Koev D; Todorova S; Diankov L; Khristova D; Tsachev K Vutr Boles; 1988; 27(2):117-22. PubMed ID: 3414094 [TBL] [Abstract][Full Text] [Related]
11. Ability of 25-hydroxyvitamin D3 therapy to augment serum 1,25- and 24,25-dihydroxyvitamin D in postmenopausal osteoporosis. Lawoyin S; Zerwekh JE; Glass K; Pak CY J Clin Endocrinol Metab; 1980 Mar; 50(3):593-6. PubMed ID: 6965678 [TBL] [Abstract][Full Text] [Related]
12. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis. Christiansen C; Rødbro P; Tjellesen L Acta Med Scand; 1984; 216(1):11-7. PubMed ID: 6385631 [TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. Gallagher JC; Jerpbak CM; Jee WS; Johnson KA; DeLuca HF; Riggs BL Proc Natl Acad Sci U S A; 1982 May; 79(10):3325-9. PubMed ID: 6954482 [TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin D metabolites on bone metabolism in a rat model of postmenopausal osteoporosis. Matsumoto T; Ezawa I; Morita K; Kawanobe Y; Ogata E J Nutr Sci Vitaminol (Tokyo); 1985 Dec; 31 Suppl():S61-5. PubMed ID: 3915757 [TBL] [Abstract][Full Text] [Related]
15. Reduction in intestinal calcium absorption by hydrochlorothiazide in postmenopausal osteoporosis. Sakhaee K; Nicar MJ; Glass K; Zerwekh JE; Pak CY J Clin Endocrinol Metab; 1984 Dec; 59(6):1037-43. PubMed ID: 6490791 [TBL] [Abstract][Full Text] [Related]
16. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women. Horowitz M; Need AG; Philcox JC; Nordin BE Horm Metab Res; 1985 Jun; 17(6):311-2. PubMed ID: 4018720 [TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women. Duda RJ; Kumar R; Nelson KI; Zinsmeister AR; Mann KG; Riggs BL J Clin Invest; 1987 Apr; 79(4):1249-53. PubMed ID: 3494046 [TBL] [Abstract][Full Text] [Related]
18. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis. Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753 [TBL] [Abstract][Full Text] [Related]
19. Bone mineral and calcium metabolism before, during and after treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium. Lindholm TS; Eriksson S Scand J Rheumatol; 1982; 11(1):55-7. PubMed ID: 7063813 [TBL] [Abstract][Full Text] [Related]
20. Does 24R,25(OH)2-vitamin D3 prevent postmenopausal bone loss? Riis BJ; Thomsen K; Christiansen C Calcif Tissue Int; 1986 Sep; 39(3):128-32. PubMed ID: 3093022 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]